RESEARCH TRIANGLE PARK, N.C., July 16, 2019 /PRNewswire/ -- Pappas Capital, a leading investor in early-stage life sciences companies, today announced the promotion of Kyle Rasbach, PhD, PharmD to a Managing Partner of Pappas Ventures, the firm's venture capital business. In his new role, Dr. Rasbach will help to oversee Pappas Ventures and

GERMANTOWN, Md., July 16, 2019 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company focused on developing novel treatments for nervous system diseases, today announced a reverse stock split of its shares of common stock at a ratio of 1-for-20. The reverse stock split will become effective on Wednesday, July 17, 2019

LAVAL, QC, July 16, 2019 /PRNewswire/ - Crescita Therapeutics Inc. ("Crescita" or the "Company") (TSX: CTX) (OTC US: CRRTF), a commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions, diseases and their symptoms, today announced that the United States

Stock Market SymbolsGIB (NYSE)GIB.A (TSX)www.cgi.com/newsroom FAIRFAX, VA, July 16, 2019 /PRNewswire/ - CGI (NYSE: GIB) (TSX

JERUSALEM, Israel, July 16, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) is proud to announce today the results of its previously announced rights offering. The Company has received subscriptions from existing shareholders for all the offered American Depositary Shares ("ADSs") and ordinary shares, being a total of 3,057,466 ADSs and 18,2

GREENSBORO, N.C., July 16, 2019 /PRNewswire/ -- MutantDx announces the awarding of patents for their ultra-sensitive Liquid Biopsy technology by the United States and European Patent Offices. This technology can identify and confirm the minute amounts of DNA cancer mutations liberated into the blood stream, while virtually

ROCKVILLE, Md., July 16, 2019 /PRNewswire/ -- More than 1,000 Maryland prescribers are making more informed prescribing decisions since adopting DrFirst's mobile medical management platform, iPrescribe, to consult the state's prescription drug monitoring program (PDMP) database. DrFirst, the nation's leading provider of e-pres

BURLINGTON, ON, July 16, 2019 /PRNewswire/ - Rapid Dose Therapeutics Corp. (CSE: DOSE), ("RDT") and Ukraine P

LONDON, July 16, 2019 /PRNewswire/ -- ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, today announced that it has expanded its intellectual property estate via the grant of a number of key patents covering its exosome technology platform. New patents have recently issued covering ReNeuron's neural stem cell-d

HOLON, Israel, July 16, 2019 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery, announced today that the United States Patent and Trademark Office (USPTO) has granted a new patent covering method of use of COM701, a first-i